ArticleFrontiers in nutrition2026
Efficacy of ketogenic diet on glycemic-lipid metabolism and menstrual regularity in women with polycystic ovary syndrome: a randomized controlled trial.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and menstrual irregularity. Ketogenic diet (KD) improves glycemic-lipid profiles and reduces inflammation, yet its efficacy on menstrual regularity in PCOS remains unclear. This trial evaluated KD effects on glycemic-lipid metabolism and menstrual restoration in PCOS women. Methods: This single-center, randomized, open-label, parallel-controlled preliminary exploratory trial enrolled 60 Chinese women with PCOS, randomly assigned to ketogenic diet (KD, Results: This study showed that improvements in body weight, waist circumference, and visceral fat area in PCOS patients were positively correlated with reductions in fasting insulin (FINS) and triglycerides (TG). Compared with SMD, the KD group demonstrated significantly greater improvements in fasting insulin, HOMA-IR, and triglycerides, and these differences remained significant after adjustment for baseline values using analysis of covariance (ANCOVA). Menstrual regularity was restored in 96.7% of KD participants versus 66.7% in the SMD group ( Conclusion: During the 12-week short-term intervention, the KD dietary intervention was superior to the SMD dietary intervention in improving insulin resistance and restoring menstrual regularity in women with PCOS. KD is suitable for acute metabolic intervention given its pronounced weight reduction and insulin sensitivity improvement; however, these findings were obtained in a single-center, exploratory trial and require validation in multi-center, larger-scale randomized controlled trials, and its long-term population impact and reproductive outcomes remain to be further investigated. SMD offers anti-inflammatory advantages and safety profiles conducive to long-term health maintenance. Therefore, a sequential strategy of initial KD followed by SMD transition is recommended to achieve sustained metabolic benefits and optimize fertility outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.